OSMR beta Protein, Cynomolgus (HEK293, His)

OSMR beta Protein, a type I cytokine receptor in the type 2 subfamily, is pivotal in cellular signaling and immune responses. Serving as the receptor for oncostatin M, a cytokine with roles in inflammation, cell growth, and differentiation, OSMR beta is crucial for downstream signaling and cellular function regulation. Exploring OSMR beta's function and regulation offers insights for developing therapeutic strategies addressing diseases associated with cytokine signaling or immune response dysregulation. OSMR beta Protein, Cynomolgus (HEK293, His) is the recombinant cynomolgus-derived OSMR beta protein, expressed by HEK293, with C-His labeled tag. The total length of OSMR beta Protein, Cynomolgus (HEK293, His) is 710 a.a., with molecular weight of 110-130 kDa.

The OSMR beta protein belongs to the type I cytokine receptor family, specifically the type 2 subfamily. This protein plays a significant role in cellular signaling and immune responses. It acts as a receptor for oncostatin M, a cytokine involved in various biological processes such as inflammation, cell growth, and differentiation. The OSMR beta protein is essential for the activation of downstream signaling pathways and the regulation of cellular functions. Understanding the function and regulation of OSMR beta protein can provide valuable insights into the development of therapeutic strategies for diseases involving dysregulation of cytokine signaling or immune responses.

Cynomolgus

HEK293

C-His

A0A2K5UFW5 (E28-S737)

102135082

110-130 kDa

Greater than 95% as determined by reducing SDS-PAGE.

<1 EU/μg, determined by LAL method.